Assiut University: Leukemia trials

The registry lists 31 Leukemia studies with Assiut University as lead sponsor. 10 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 1No phase 28(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Musculoskeletal Ultrasound in Patients With Hematologic MalignanciesNot yet recruitingNCT07785505
• What is the Impact of TKI on Thyroid Function in CML Patients?Not yet recruitingNCT07200882
• Expression Pattern and Possible Clinical Significance of CD81 In Myeloid LeukemiaNot yet recruitingNCT07146542
• Evaluation of CD47, "Do Not Eat Me" Signal Expression in Chronic Myeloid LeukemiaNot yet recruitingNCT06865443
• Atorvaststin and Cardiotoxicity in Acute Myloid LeukemiaNot yet recruitingNCT06684509Phase 1/2
• Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic LeukemiaNot yet recruitingNCT06674850
• The Prognostic Role of Fibrinogen to Albumin Ratio in Acute Leukemia PatientsNot yet recruitingNCT06668948
• The Role of NK Cells to Detect Blood Infection in ALL.Not yet recruitingNCT06160115
• H19 in Acute Lymphoblastic Leukemia.Not yet recruitingNCT05943093
• Frequency and Risk Factors of Acute Myeloid LeukemiaNot yet recruitingNCT05787951
• Psychiatric Problems in Children With Acute Lymphoblastic Leukemia and Their CaregiversActive, not recruitingNCT06723496
• CD155 Expression in Acute Myeloid LeukemiaCompletedNCT06369662
• Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 ExpressionStatus unknownNCT05512104
• FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Status unknownNCT05383014
• TIGIT in Patients With Chronic Myeloid LeukemiaStatus unknownNCT04818619
• Assesment of JL1 Expression in Acute LeukemiaStatus unknownNCT04554381Phase 1
• Vitamin D and Methotrexate Adverse EffectsStatus unknownNCT04488237
• Outcomes of Acute Myeloid Leukemia PatientsStatus unknownNCT04392310
• Immunophenotyping and Xist Gene in AMLStatus unknownNCT04288739
• PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid LeukemiaStatus unknownNCT04215822
• Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate ChemotherapyStatus unknownNCT04096846
• FoxO3a and PU.1 in Acute Lymphoblastic LeukemiaStatus unknownNCT04092348
• Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer InstituteStatus unknownNCT03743909
• Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AMLCompletedNCT03719183
• Cd11b and Cd56 as Prognostic Markers in Acute Myeloid LeukemiaStatus unknownNCT03283228
• Expression of TET1 Gene in Acute LeukaemiaStatus unknownNCT03267485
• Effect of Pharmacogenetics on Imatinib Plasma Level and ResponseCompletedNCT03262974
• New Markers for Minimal Residual Disease in Acute Lymphoblastic LeukemiaStatus unknownNCT03249636
• Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid LeukemiaStatus unknownNCT03228303Early Phase 1
• Myeloid Derived Suppressor Cells and Chronic Myeloid LeukemiaStatus unknownNCT03214718Not applicable
• C-X-C Chemokine Receptor 4 in Chronic Lymphocytic LeukemiaStatus unknownNCT03150849